Stem Cells for Treating Critical Ischemia
Unknown statusPhase 1NCT00488020
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Collection of bone marrow blood Selection of mononuclear cells dilution with albumin injection into the calf muscles through 40 shots
Study details
- Official title
- the Use of Autogenous Adult Stem Cells in the Treatment of Critical Ischemia
- Conditions
- Critical Limb Ischemia
- Ischemic Ulcers
- Interventions
- Procedure: stem cells transplant
- Sponsor
- Instituto de Molestias Cardiovasculares
- Start date
- 2006-04
- Sex
- All
- Age range
- from 30 Years to 80 Years
- Results posted
- No results posted in this snapshot
- Countries
- Brazil
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Fontaine's classification grade 3 and 4 patients Exclusion Criteria: * Record of cancer in the last 5 years * Over 80 years * Diabetic retinopathy
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT00488020